Insider Transactions in Q1 2018 at Cvs Health Corp (CVS)
Insider Transaction List (Q1 2018)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 28
2018
|
Thomas M Moriarty EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
4,650
+10.1%
|
$311,550
$67.73 P/Share
|
|
Feb 28
2018
|
Jonathan C Roberts EVP & Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,979
+3.54%
|
$400,593
$67.73 P/Share
|
|
Feb 28
2018
|
Larry J Merlo Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,616
+2.25%
|
$979,272
$67.73 P/Share
|
|
Feb 28
2018
|
David M Denton EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,613
-6.8%
|
$108,071
$67.73 P/Share
|
|
Feb 28
2018
|
David M Denton EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
5,315
+18.31%
|
$356,105
$67.73 P/Share
|
|
Feb 28
2018
|
Troyen A Brennan EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,208
-1.49%
|
$80,936
$67.73 P/Share
|
|
Feb 28
2018
|
Troyen A Brennan EVP and Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,986
+4.69%
|
$267,062
$67.73 P/Share
|
|
Feb 28
2018
|
Lisa Bisaccia Former EVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
885
-4.79%
|
$59,295
$67.73 P/Share
|
|
Feb 28
2018
|
Lisa Bisaccia Former EVP & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,923
+13.66%
|
$195,841
$67.73 P/Share
|
|
Feb 28
2018
|
Eva C Boratto EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
517
-0.64%
|
$34,639
$67.73 P/Share
|
|
Feb 28
2018
|
Eva C Boratto EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
797
+1.92%
|
$53,399
$67.73 P/Share
|
|
Feb 27
2018
|
Eva C Boratto EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
197
-0.5%
|
$13,396
$68.25 P/Share
|
|
Feb 20
2018
|
David M Denton EVP and CFO |
SELL
Other acquisition or disposition
|
Direct |
18,057
-49.53%
|
-
|
|
Feb 20
2018
|
David M Denton EVP and CFO |
SELL
Other acquisition or disposition
|
Direct |
38,836
-25.4%
|
-
|
|
Feb 16
2018
|
Helena Foulkes EVP & President-CVS Pharmacy |
SELL
Open market or private sale
|
Direct |
19,965
-30.68%
|
$1,417,515
$71.04 P/Share
|
|
Feb 16
2018
|
Helena Foulkes EVP & President-CVS Pharmacy |
BUY
Exercise of conversion of derivative security
|
Direct |
19,965
+23.48%
|
$898,425
$45.07 P/Share
|